Home » Stocks » AMPE

Ampio Pharmaceuticals, Inc. (AMPE)

Stock Price: $1.71 USD 0.02 (1.18%)
Updated Feb 26, 2021 4:00 PM EST - Market closed
Market Cap 316.44M
Revenue (ttm) n/a
Net Income (ttm) -12.30M
Shares Out 178.62M
EPS (ttm) -0.11
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day February 26
Last Price $1.71
Previous Close $1.69
Change ($) 0.02
Change (%) 1.18%
Day's Open 1.83
Day's Range 1.63 - 1.83
Day's Volume 1,844,041
52-Week Range 0.31 - 2.98

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
The Motley Fool - 1 month ago

Investors weren't comfortable with FDA feedback on the company's late-stage clinical trial.

The Motley Fool - 2 months ago

2020 is almost over. Maybe it's time to cash in -- and cash out?

Other stocks mentioned: BLNK, DNLI, MDB
Zacks Investment Research - 2 months ago

Investors need to pay close attention to Ampio Pharmaceuticals (AMPE) stock based on the movements in the options market lately.

Zacks Investment Research - 2 months ago

Investors need to pay close attention to Ampio (AMPE) stock based on the movements in the options market lately.

Seeking Alpha - 3 months ago

Ampio Pharmaceuticals, Inc. (AMPE) CEO on Q3 2020 Earnings Results - Conference Call Transcript

InvestorPlace - 4 months ago

If you're itching for a little excitement in your investing, these cheap stocks under $1 might be just what you're looking for. The post 7 Cheap Stocks Under $1 That Deserve A Second Look appe...

Other stocks mentioned: GPL, GPOR, GSM, MTNB, TRQ, TRX
Seeking Alpha - 5 months ago

Ampio’s delayed pivotal phase 3 trial for severe OAK to resume.

InvestorPlace - 6 months ago

These seven penny stocks have the right catalysts, business models, and tailwinds. Read about why the risk is worth it.

Other stocks mentioned: BIOC, BOXL, EMAN
Zacks Investment Research - 7 months ago

Ampio Pharmaceuticals (AMPE) saw a big move last session, as its shares jumped nearly 9% on the day, amid huge volumes.

Seeking Alpha - 10 months ago

Finding The Kink In COVID-19's Armor - Preventing ARDS

Other stocks mentioned: CYDY, GALT, GILD, RHHBY
Zacks Investment Research - 10 months ago

Ampio (AMPE) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.

Zacks Investment Research - 10 months ago

Investors need to pay close attention to Ampio (AMPE) stock based on the movements in the options market lately.

About AMPE

Ampio Pharmaceuticals, a biopharmaceutical company, focuses on the development of therapies for the treatment of prevalent inflammatory conditions in the United States. It is developing compounds that decrease inflammation by inhibiting specific pro-inflammatory compounds. The company's product pipeline includes Ampion, which is in phase III clinical trial, is an intra-articular injection for the treatment of osteoarthritis of the knee. Ampio Pharmaceuticals, Inc. has collaborative research agreements to explore new clinical indications for its... [Read more...]

Industry
Biotechnology
CEO
Michael Macaluso
Employees
23
Stock Exchange
NYSEAMERICAN
Ticker Symbol
AMPE
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecasts

According to one analyst, the rating for AMPE stock is "Buy" and the 12-month stock price forecast is 4.50.

Price Target
$4.50
Analyst Consensus: Buy